Loading...

Genetic Clinics

Volume 6 | Issue 4 | October-December 2013

GeNeDit

October-December 2013 | Vol 6 | Issue 4 | Pages 1-2

Prenatal Diagnosis – Over the Counter / Direct to Consumer Testing

Prenatal diagnosis was a very revolutionary concept in the prevention of a disease. Though it appears a very radical method, it got accepted almost worldwide and now has become an integral part of obstetric care. Availability of screening of all pregnant women for relatively common disorders like neural tube defects, thalassemia major and Down syndrome was another milestone in the prevention of genetic disorders....

Shubha R Phadke


ClinicalVignette

October-December 2013 | Vol 6 | Issue 4 | Pages 3-5

Mesomelic limb defects: a handle for prenatal diagnosis of Trisomy 18 syndrome

Trisomy 18 has been recognised as a definitive syndrome since 1960 when it was first described by Edwards et al. and is the second most common multiple malformation syndrome. The prevalence is approximately 1/6,000-1/8,000 live births and the overall prevalence, taking into account fetal losses and pregnancy terminations after prenatal 1 diagnosis, is 1/2500-1/2600...

Anju Shukla, Rekha Gupta, Moni Tuteja, Shubha R Phadke


GeNeViSTA

October-December 2013 | Vol 6 | Issue 4 | Pages 6-11

Cytogenetic Microarray: A revolution in Cytogenetics

Intellectual disability (ID) is the most common clinical situation encountered in medical genetics for counseling. Confirmation of diagnosis is the first step to provide prognosis, genetic counseling and option of prenatal diagnosis to the family. Despite the exhaustive investigations, etiology remains 1 unidentified in 30-50% of the cases. With the advent of molecular cytogenetic techniques...

Dr Meenal Agarwal


GeNeViSTA

October-December 2013 | Vol 6 | Issue 4 | Pages 12-18

Fetal Therapy- Current approaches and future possibilities

Strictly speaking, fetal therapy is defined as a therapeutic intervention for the purpose of correcting or treating a fetal anomaly or condition. However, in a broader sense, it encompasses any prenatal treatment administered to the mother with the primary indication to improve perinatal or long-term outcomes for the fetus or newborn...

Dr Shagun Aggarwal


HearToHearTalk

October-December 2013 | Vol 6 | Issue 4 | Pages 19-20

Short – on sensitivity!

Jayant and Rashmi (names changed) were married for a year now. It was a dream come true for Rashmi's three brothers- Anil, Anuj and Vimal (names changed). It was a perfect marriage and the couple looked beautiful together. Rashmi was young, slim, tall and pretty as a 'picture'.Jayant was a handsome young man and well settled financially...

Divya Aggarwal, Shubha R Phadke


GeNeXprESS

October-December 2013 | Vol 6 | Issue 4 | Pages 21

Inactivating the extra chromosome in Down syndrome

Down syndrome is the leading genetic cause of intellectual disability and millions of Down syndrome patients across the world also face multiple other health issues. Jiang et al tried the first chromosome therapy for Down syndrome with the idea of dosage compensation correction. They inserted the XIST gene in to the DYRK1A locus on chromosome 21 of induced pluripotent stem (iPS) cells derived from a Down syndrome patient...

SriLakshmi Bhavani


Visitors Count: 32579

Powered By: logo